Skip to main content
Log in

Drug Safety

The Official Journal of the International Society of Pharmacovigilance [ISoP]

Publishing model:

Overview

The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.

As a hybrid journal, Drug Safety does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.

Drug Safety offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Drug Safety is the official journal of the International Society of Pharmacovigilance (ISoP). The official representative for the Society is Dr Angela Caro Rojas, ISoP President (administration@isoponline.org).

Editor
  • Nitin Joshi
Impact factor
4.2 (2022)
5 year impact factor
4.3 (2022)
Submission to first decision (median)
20 days
Downloads
819,378 (2023)

Latest articles

Journal updates

  • Digital Features

    Drug Safety is able to host a range of digital features, with a number of options available to authors.

Journal information

Electronic ISSN
1179-1942
Print ISSN
0114-5916
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Baidu
  4. CLOCKSS
  5. CNKI
  6. CNPIEC
  7. Chemical Abstracts Service (CAS)
  8. Current Contents/Clinical Medicine
  9. Dimensions
  10. EBSCO
  11. EMBASE
  12. EMCare
  13. Google Scholar
  14. Japanese Science and Technology Agency (JST)
  15. Medline
  16. Naver
  17. OCLC WorldCat Discovery Service
  18. Pathway Studio
  19. Portico
  20. ProQuest
  21. Reaxys
  22. SCImago
  23. SCOPUS
  24. Science Citation Index Expanded (SCIE)
  25. Semantic Scholar
  26. TD Net Discovery Service
  27. UGC-CARE List (India)
  28. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG

Navigation